The Electrical
Management of
Cardiac Rhythm
Disorders
History of ICD
By
Dr. Kush Kumar Bhagat
The Genesis of
ICDs
● The idea of the ICD came to Dr. Michel
Mirowski when his friend died of SCD
● Concept: could a defibrillator be implanted
in the body?
● Technological challenges
○ Could an implantable device deliver
sufficient energy?
○ Could leads be developed to carry that
much energy?
○ How would the device detect
arrhythmias?
○ How could defibrillation become
“automated”?
Dr. Michel
Mirowski
● Dr. Harry Heller died of SCD in 1966
● His friend, Dr. Michel Mirowski, knew that he
might have lived had he received
defibrillation immediately
● Technological and even ethical hurdles
○ Was it ethical to even test such a device
on humans?
● By 1969, Dr. Mirowski was working on the first
experimental models of what would later
become the ICD
● But it would be almost 20 years before the
device was commercially available!
Timeline
● Sinai Hospital of Baltimore recruited Dr.
Mirowski and offered him opportunity to work
on ICD idea
● At Sinai, Mirowski teamed up with Martin Mower
in the research lab
● In 1969, experimental model
● First transvenous defibrillation (1969)
● Canine implants (1970s)
● First human implant: 1980 (Johns Hopkins,
Baltimore)
Technological Challenges
● Capacitor technology allowed small battery to store and deliver large amount
of energy
● Transvenous defibrillation leads could carry defibrillation energy to the inside
of the heart
● Circuitry could sense cardiac rhythms and interpret potentially
dangerous ventricular tachyarrhythmias
● Device could be downsized enough to implant in the body
Early Devices
● 1980-1985 clinical trial of first ICDs
● 1985 FDA approved first ICD for human use
● Those first devices were 10 times the size of
modern ICDs!
● Their large size mandated an abdominal
implant
● Thoracotomy required to implant leads
Road to
ICDs
ICD Evolution
● Cardioversion (lower-energy shocks) and “tiered therapy”
● Programmability (1988)
○ First ICDs were custom-built since cutoff rates were set at the factory!
● Biphasic waveforms
● Multiple zones (VT/VF)
● Transvenous ICD leads
● Radically downsized generators (pectoral implants)
● Full-featured integrated pacemakers
ICD Header (Connecting Port)
Defibrillation Leads
Single-Coil
Defib Leads
● Pacing requires one or more electrodes on
the lead to pace sense
● Shocking requires one or more “coils” on
the lead to defibrillate
● A single-coil lead has one coil on the lead
and forms the electrical circuit by using the
ICD can as the other pole to complete the
circuit
● Improve Extractability.
Modern Defibrillation Leads
● Integrated bipolar and true bipolar leads
○ Refers to sensing cardiac signals
○ Integrated bipolar uses distal shocking coil to sense cardiac signals
○ True bipolar has dedicated distal sensing electrode
● Single-coil and dual-coil designs
● Very thin, comparable to some pacing leads!
● Choice of lead fixation mechanisms
○ Active fixation (helix, corkscrew)
○ Passive fixation (fins, tines)
● Steroid elution
Progress: The
Implant Procedure
THEN
● Open-chest
● Took several hours
● General anesthesia
● Several days hospital stay
● Large device
● Abdominal implant
● No or very limited
programmability
Progress: Device Functionality
THEN
• Very few Programmable options
• Short Service Life
• Only ONE Therapy (Defib)
• No Pacing Capability( If Pacing needed, a
second device might be required
• Could only be monitored in- Clinic
NOW
• Lots of Programmability including Advanced
Features
• Long Service Life up to 15 years
• Tiered Therapy, Even ATP Before Charging
• Full Pacing Capability including some Dual
Chamber rate response pacing with advanced
features
• Remote Patient Monitoring
Device Acceptance
● The first ICDs were considered a device of last resort
○ Patients had to be drug-refractory and survived at least two episodes of
SCD
● Early concepts pitted drugs against devices as if they were mutually
exclusive
● Devices became acceptable as first-line therapy for certain types of
secondary-prevention patients
● Today, we know devices can provide additive benefits to drug therapy and that
combination therapy (drugs plus devices) is ideal for most patients
● Recent studies have shown the mortality benefits of primary prevention
therapy
The Future of ICDs
● Smaller, flatter devices, physiocurve (improved capacitor
technology)
● Longer-lived devices (improved battery technology)
● Remote patient monitoring ( e.g., Medtronic Carelink Remote
Monitoring)
● FDA approved full body 1.5 T & 3 T MRI devices
● Wireless patient monitoring(while doing device Interrogation in
clinic)
● Special algorithms (to Reduce In-appropriate shocks)
● Single Lead VDD ICD
● More automatic features(smart shock technologies)
● Audible Alert in case of ERI etc.
● Built-in monitors( Bluetooth enabled devices)
● Single Chamber ICD able to Identify Atrial Arryhtmia
S-ICD
• Subcutaneous Implantable
Cardioverter defibrillator
• Beneficial for the Patient with no
venous access who were
unsuitable for transvenous ICD.
• There is no risk of vascular Injury
or pneumothorax
This Photo by Unknown Author is licensed under CC BY-NC-ND
THANK YOU

Dr. Kush ICD ppt.pptx

  • 1.
    The Electrical Management of CardiacRhythm Disorders History of ICD By Dr. Kush Kumar Bhagat
  • 2.
    The Genesis of ICDs ●The idea of the ICD came to Dr. Michel Mirowski when his friend died of SCD ● Concept: could a defibrillator be implanted in the body? ● Technological challenges ○ Could an implantable device deliver sufficient energy? ○ Could leads be developed to carry that much energy? ○ How would the device detect arrhythmias? ○ How could defibrillation become “automated”?
  • 3.
    Dr. Michel Mirowski ● Dr.Harry Heller died of SCD in 1966 ● His friend, Dr. Michel Mirowski, knew that he might have lived had he received defibrillation immediately ● Technological and even ethical hurdles ○ Was it ethical to even test such a device on humans? ● By 1969, Dr. Mirowski was working on the first experimental models of what would later become the ICD ● But it would be almost 20 years before the device was commercially available!
  • 4.
    Timeline ● Sinai Hospitalof Baltimore recruited Dr. Mirowski and offered him opportunity to work on ICD idea ● At Sinai, Mirowski teamed up with Martin Mower in the research lab ● In 1969, experimental model ● First transvenous defibrillation (1969) ● Canine implants (1970s) ● First human implant: 1980 (Johns Hopkins, Baltimore)
  • 5.
    Technological Challenges ● Capacitortechnology allowed small battery to store and deliver large amount of energy ● Transvenous defibrillation leads could carry defibrillation energy to the inside of the heart ● Circuitry could sense cardiac rhythms and interpret potentially dangerous ventricular tachyarrhythmias ● Device could be downsized enough to implant in the body
  • 6.
    Early Devices ● 1980-1985clinical trial of first ICDs ● 1985 FDA approved first ICD for human use ● Those first devices were 10 times the size of modern ICDs! ● Their large size mandated an abdominal implant ● Thoracotomy required to implant leads
  • 7.
  • 8.
    ICD Evolution ● Cardioversion(lower-energy shocks) and “tiered therapy” ● Programmability (1988) ○ First ICDs were custom-built since cutoff rates were set at the factory! ● Biphasic waveforms ● Multiple zones (VT/VF) ● Transvenous ICD leads ● Radically downsized generators (pectoral implants) ● Full-featured integrated pacemakers
  • 9.
  • 10.
  • 11.
    Single-Coil Defib Leads ● Pacingrequires one or more electrodes on the lead to pace sense ● Shocking requires one or more “coils” on the lead to defibrillate ● A single-coil lead has one coil on the lead and forms the electrical circuit by using the ICD can as the other pole to complete the circuit ● Improve Extractability.
  • 12.
    Modern Defibrillation Leads ●Integrated bipolar and true bipolar leads ○ Refers to sensing cardiac signals ○ Integrated bipolar uses distal shocking coil to sense cardiac signals ○ True bipolar has dedicated distal sensing electrode ● Single-coil and dual-coil designs ● Very thin, comparable to some pacing leads! ● Choice of lead fixation mechanisms ○ Active fixation (helix, corkscrew) ○ Passive fixation (fins, tines) ● Steroid elution
  • 13.
    Progress: The Implant Procedure THEN ●Open-chest ● Took several hours ● General anesthesia ● Several days hospital stay ● Large device ● Abdominal implant ● No or very limited programmability
  • 14.
    Progress: Device Functionality THEN •Very few Programmable options • Short Service Life • Only ONE Therapy (Defib) • No Pacing Capability( If Pacing needed, a second device might be required • Could only be monitored in- Clinic NOW • Lots of Programmability including Advanced Features • Long Service Life up to 15 years • Tiered Therapy, Even ATP Before Charging • Full Pacing Capability including some Dual Chamber rate response pacing with advanced features • Remote Patient Monitoring
  • 15.
    Device Acceptance ● Thefirst ICDs were considered a device of last resort ○ Patients had to be drug-refractory and survived at least two episodes of SCD ● Early concepts pitted drugs against devices as if they were mutually exclusive ● Devices became acceptable as first-line therapy for certain types of secondary-prevention patients ● Today, we know devices can provide additive benefits to drug therapy and that combination therapy (drugs plus devices) is ideal for most patients ● Recent studies have shown the mortality benefits of primary prevention therapy
  • 16.
    The Future ofICDs ● Smaller, flatter devices, physiocurve (improved capacitor technology) ● Longer-lived devices (improved battery technology) ● Remote patient monitoring ( e.g., Medtronic Carelink Remote Monitoring) ● FDA approved full body 1.5 T & 3 T MRI devices ● Wireless patient monitoring(while doing device Interrogation in clinic) ● Special algorithms (to Reduce In-appropriate shocks) ● Single Lead VDD ICD ● More automatic features(smart shock technologies) ● Audible Alert in case of ERI etc. ● Built-in monitors( Bluetooth enabled devices) ● Single Chamber ICD able to Identify Atrial Arryhtmia
  • 17.
    S-ICD • Subcutaneous Implantable Cardioverterdefibrillator • Beneficial for the Patient with no venous access who were unsuitable for transvenous ICD. • There is no risk of vascular Injury or pneumothorax This Photo by Unknown Author is licensed under CC BY-NC-ND
  • 18.